[What do paediatricians and mothers talk about in the well-child program visits?]

C Nunes1, M Ayala

  • 1Departamento de Psicología, Universidad del Algarve, Faro, Portugal. csnunes@ualg.pt

Insights

Paediatricians provide essential child development and education counseling. This study analyzed 49 visits, finding dense content and varied paediatrician styles, but no communication barriers related to maternal education.

Area of Science:

  • Pediatric medicine
  • Developmental pediatrics
  • Health communication

Context:

  • Paediatricians are a primary source of formal counseling for parents regarding child development and education.
  • Limited understanding exists regarding the specific content and characteristics of paediatrician counseling practices.
  • This study addresses this gap by analyzing visit duration, discussed topics, and parent-pediatrician initiatives.

Purpose:

  • To analyze the content and characteristics of paediatrician counseling during child development and education visits.
  • To examine visit duration, topics discussed, and the initiatives of both parents and paediatricians.
  • To identify variations in paediatrician practices and communication dynamics.

Summary:

  • A content analysis of 49 paediatrician visits revealed dense counseling sessions (14.3 topics/visit) within recommended durations (M=16.1 min).
  • Paediatrician priorities included feeding, diseases, and psychomotor development, while mothers focused on minor health issues, growth, and behavior.
  • Significant differences in counseling dimensions were noted among paediatricians, with balanced communication and no identified barriers related to maternal education level.

Impact:

  • Highlights the diversity in paediatrician counseling styles, offering insights for professional development and practice improvement.
  • Demonstrates balanced communication dynamics between paediatricians and mothers, with no educational barriers.
  • Suggests incorporating more psychosocial topics to enhance pediatric counseling programs and support child development and education initiatives.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...